SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-033672
Filing Date
2024-08-23
Accepted
2024-08-23 14:38:42
Documents
24
Period of Report
2024-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62661
2 ex5-1.htm EX-5.1 26184
3 ex10-110.htm EX-10.110 126397
4 ex10-111.htm EX-10.111 56721
5 ex10-112.htm EX-10.112 129435
6 ex10-113.htm EX-10.113 125012
7 ex10-114.htm EX-10.114 55001
8 ex10-115.htm EX-10.115 129253
9 ex23-2.htm EX-23.2 4045
10 ex5-1_001.jpg GRAPHIC 1873
11 ex5-1_002.jpg GRAPHIC 2069
  Complete submission text file 0001493152-24-033672.txt   1046256

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE alts-20240820.xsd EX-101.SCH 3018
13 XBRL LABEL FILE alts-20240820_lab.xml EX-101.LAB 34916
14 XBRL PRESENTATION FILE alts-20240820_pre.xml EX-101.PRE 24597
27 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3854
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241235760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)